Parkinson disease, substantia nigra vulnerability, and calbindin expression: Enlightening the darkness?

Mov Disord. 2019 Feb;34(2):161-163. doi: 10.1002/mds.27618. Epub 2019 Jan 24.

Authors

Javier Blesa^{1

2}, Miquel Vila^{2

3}

Affiliations

¹ HM CINAC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain.
² CIBERNED, Instituto Carlos III, Spain.
³ Vall d'Hebron Research Institute-Catalan Institution for Research and Advanced Studies, Barcelona, Spain.

PMID: 30675930
DOI: 10.1002/mds.27618

No abstract available

Publication types

Editorial
Comment

MeSH terms

Calbindins
Darkness
Dopaminergic Neurons
Humans
MPTP Poisoning*
Parkinson Disease*
Substantia Nigra

Substances

Calbindins